February 19, 2019
CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is pleased to announce expansion of the role of Melanie Bruno to Vice President of Global Clinical Project Management.
“We are happy to recognize the growth of Melanie's role to cover all of our clinical project management services and operations around the world,” remarks Kevin Schwarz, Chief Operating Officer. “She has been an asset to the company since she joined the team, and we look forward to the impact she will have on our global department for years to come.”
Melanie Bruno, PhD, MBA, joined CTI in 2012 and has more than 25 years of clinical drug development experience in the pharmaceutical and clinical research industries. Before joining CTI, Melanie served as Vice President of Global Regulatory and Medical Affairs at Kendle International. After completing her postdoctoral work in Molecular Biology at Cincinnati Children’s Hospital Medical Center (CCHMC), Melanie held positions in Regulatory Affairs with Proctor & Gamble Pharmaceuticals and Eli Lilly. In addition to her current role at CTI, Melanie is an Adjunct Professor at the College of Pharmacy at the University of Cincinnati for the Masters in Drug Development program and is an Adjunct Professor at Northern Kentucky University for the Certificate in Clinical Research program, a program she was instrumental in starting. Melanie received her Master of Business Administration and her Doctor of Philosophy in Developmental Biology from the University of Cincinnati.